GI & Endoscopy

The FDA granted four GI-related device clearances in January.

David Freeto, MD, is a gastroenterologist at Napa, Calif.-based Queen of the Valley Medical Center.

Burlington, Mass.-based ArQule's and Tokyo, Japan-based Daiichi Sankyo's drug, tivantinib, failed to meet its primary endpoint of improving hepatocellular carcinoma patients' survival rate.

Henrico-based Virginia Endoscopy Group added two procedure rooms and five recovery bays in a recent expansion, the Richmond Times-Dispatch reports.

Here are the five most read gastroenterology/endoscopy stories from Feb. 13 to Feb. 17, 2017.

Andrew Minkin, MD, is a gastroenterologist with Berlin, Vt.-based Green Mountain Gastroenterology.

Here are three gastroenterologists in the news this past week.

Japan-based Takeda acquired Cambridge, Mass.-based Ariad Pharmaceuticals for $24 per share, Yahoo! Finance reports.

Japan-based Takeda and Leuven, Belgium-based TiGenix NB reported positive data from Admire-CD's Cx601 phase III clinical trial.

The World Congress of GI Endoscopy 2017 began in Telangana, India, The Hindu reports.